Structured Review

NeuroMab mouse anti kchip2 k60 73
Transcripts showing statistically most significant LA expression differences between young and old swine.
Mouse Anti Kchip2 K60 73, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2 k60 73/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 k60 73 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "NHE Isoform Switching and KChIP2 Upregulation in Aging Porcine Atria"

Article Title: NHE Isoform Switching and KChIP2 Upregulation in Aging Porcine Atria

Journal: PLoS ONE

doi: 10.1371/journal.pone.0082951

Transcripts showing statistically most significant LA expression differences between young and old swine.
Figure Legend Snippet: Transcripts showing statistically most significant LA expression differences between young and old swine.

Techniques Used: Expressing

A. Mean KChIP2 ( KCNIP2 ) transcript expression quantified by real-time qPCR, standardized to GAPDH expression in each sample and then normalized to expression measured from a single young pig LA sample. **p<0.01, old v young; all others p>0.05; n = 3–5. B. Upper : mean cardiac KChIP2 protein expression visualized by western blotting, standardized by total protein for loading. Lower : GAPDH expression for comparison. Each lane is from a different individual. C. Mean cardiac KChIP2 protein expression quantified by band densitometry of blots as in panel F, normalized to GAPDH expression. *p<0.05 old v young; n = 3–4. D. In silico modeling data showing the predicted effects of 3.8-fold KChIP2 upregulation on human atrial myocyte I to ( lower ) and action potential morphology ( upper ).
Figure Legend Snippet: A. Mean KChIP2 ( KCNIP2 ) transcript expression quantified by real-time qPCR, standardized to GAPDH expression in each sample and then normalized to expression measured from a single young pig LA sample. **p<0.01, old v young; all others p>0.05; n = 3–5. B. Upper : mean cardiac KChIP2 protein expression visualized by western blotting, standardized by total protein for loading. Lower : GAPDH expression for comparison. Each lane is from a different individual. C. Mean cardiac KChIP2 protein expression quantified by band densitometry of blots as in panel F, normalized to GAPDH expression. *p<0.05 old v young; n = 3–4. D. In silico modeling data showing the predicted effects of 3.8-fold KChIP2 upregulation on human atrial myocyte I to ( lower ) and action potential morphology ( upper ).

Techniques Used: Expressing, Western Blot, In Silico


Structured Review

NeuroMab mouse monoclonal anti kchip2
Mouse Monoclonal Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse monoclonal anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

NeuroMab mouse anti kchip2
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images


Structured Review

NeuroMab mouse monoclonal anti kchip2
(A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), <t>KChIP2</t> (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.
Mouse Monoclonal Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse monoclonal anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "The potassium channel Kv4.2 regulates dendritic spine morphology, electroencephalographic characteristics and seizure susceptibility in mice"

Article Title: The potassium channel Kv4.2 regulates dendritic spine morphology, electroencephalographic characteristics and seizure susceptibility in mice

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2020.113437

(A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), KChIP2 (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.
Figure Legend Snippet: (A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), KChIP2 (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.

Techniques Used: MANN-WHITNEY, Western Blot


Structured Review

NeuroMab mouse monoclonal anti kchip2
(A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), <t>KChIP2</t> (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.
Mouse Monoclonal Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse monoclonal anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "The potassium channel Kv4.2 regulates dendritic spine morphology, electroencephalographic characteristics and seizure susceptibility in mice"

Article Title: The potassium channel Kv4.2 regulates dendritic spine morphology, electroencephalographic characteristics and seizure susceptibility in mice

Journal: Experimental neurology

doi: 10.1016/j.expneurol.2020.113437

(A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), KChIP2 (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.
Figure Legend Snippet: (A, B) Kv4.2 protein (A) and mRNA levels (B) are significantly reduced in Kv4.2HET mice compared with WT control (unpaired t-tests, WT: n=11, HET: n=12; A: t(21)=7.4, *p<0.0001; B: t(21)=8.3, *p<0.0001). (C) In contrast, Kv4.3 protein levels were unchanged (unpaired t-test, WT: n=11, HET: n=12; t(21)=1.1, p=0.286). (D-I) Of all tested auxiliary subunits of the Kv4.2 complex, only KChIP3 (D,F) was significantly reduced, whereas DPP6 (E,F), KChIP2 (G,I) and DPP10 (H,I) were unchanged (D: unpaired t-test, n=11, t(20)=2.97, p=0.008; E: unpaired t-test, n=11, t(20)=1.67, p=0.11; G: Mann Whitney test, WT: n=11, HET: n=12, p=0.83; H: Mann Whitney test, WT: n=11, HET: n=12, p=0.79). Example Western Blots are shown on top in A and C, as well as in F for D and E, and in I for G and H. An additional example of western blots shown in F is shown in Fig. S1A. DPP6 and KChIP3 were either normalized to Akt or βActin, which did not differ between genotypes (Fig. S1B). Error bars represent SEM.

Techniques Used: MANN-WHITNEY, Western Blot


Structured Review

NeuroMab mouse anti kchip2
Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, <t>KChIP2-,</t> and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control"

Article Title: K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control

Journal: The Journal of Neuroscience

doi: 10.1523/JNEUROSCI.1619-16.2017

Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.
Figure Legend Snippet: Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.

Techniques Used: Expressing, Injection

Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.
Figure Legend Snippet: Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.

Techniques Used: Isolation, Western Blot, Immunoprecipitation


Structured Review

NeuroMab mouse anti kchip2
Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, <t>KChIP2-,</t> and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control"

Article Title: K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control

Journal: The Journal of Neuroscience

doi: 10.1523/JNEUROSCI.1619-16.2017

Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.
Figure Legend Snippet: Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.

Techniques Used: Expressing, Injection

Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.
Figure Legend Snippet: Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.

Techniques Used: Isolation, Western Blot, Immunoprecipitation


Structured Review

NeuroMab mouse anti kchip2
Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, <t>KChIP2-,</t> and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control"

Article Title: K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control

Journal: The Journal of Neuroscience

doi: 10.1523/JNEUROSCI.1619-16.2017

Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.
Figure Legend Snippet: Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.

Techniques Used: Expressing, Injection

Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.
Figure Legend Snippet: Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.

Techniques Used: Isolation, Western Blot, Immunoprecipitation


Structured Review

NeuroMab mouse anti kchip2
Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, <t>KChIP2-,</t> and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control"

Article Title: K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control

Journal: The Journal of Neuroscience

doi: 10.1523/JNEUROSCI.1619-16.2017

Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.
Figure Legend Snippet: Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.

Techniques Used: Expressing, Injection

Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.
Figure Legend Snippet: Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.

Techniques Used: Isolation, Western Blot, Immunoprecipitation


Structured Review

NeuroMab mouse anti kchip2
Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, <t>KChIP2-,</t> and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
mouse anti kchip2 - by Bioz Stars, 2024-07
86/100 stars

Images

1) Product Images from "K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control"

Article Title: K + Channel Modulatory Subunits KChIP and DPP Participate in Kv4-Mediated Mechanical Pain Control

Journal: The Journal of Neuroscience

doi: 10.1523/JNEUROSCI.1619-16.2017

Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: Intrathecal injection of Kv4.3 ASO reduces all Kv4 complex components in the L4–L6 DRGs. Rats were intrathecally injected with Kv4.3 ASO twice daily for 3 consecutive days (D1–D3) and killed on day 4 (D4) or D7. Rats injected with vehicle (V) or LacZ ASO (Z) were used as controls. A, In the L5 DRG of rats treated with Kv4.3 ASO, Kv4.3-, KChIP1-, KChIP2-, and DPP10-IR were greatly reduced on D4 but returned to the normal levels on D7. Scale bar, 40 μm. B–E, Quantitative data of A. C, C7 DRG. L, L5 DRG. F–I, Western blotting was performed using total proteins (F, G) or plasma membrane proteins (H, I) isolated from the bilateral L4–L6 DRGs on D4. Kv4.3 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. Bands of GAPDH and cadherin were loading controls for total proteins and plasma membrane proteins, respectively. Data are mean ± SD (n = 3). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).
Figure Legend Snippet: KChIP1 or KChIP2 ASO reduces all Kv4 complex components in the DRGs and induces mechanical hypersensitivity. Rats were intrathecally injected with vehicle, LacZ ASO, KChIP1 ASO, or KChIP2 ASO during D1–D3. A, B, KChIP1 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. L, Left side; R, right side. Data are mean ± SEM (n = 6). *p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). **p < 0.05, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). ***p < 0.001, compared with the baseline (BL) on the corresponding side (Tukey's post hoc test after one-way ANOVA). C–F, Rats were killed on D4 after ASO treatment. Western blotting was performed using total proteins (C, D) or plasma membrane proteins (E, F) isolated from the bilateral L4–L6 DRGs on D4. KChIP1 ASO treatment reduces Kv4.3, KChIP1, and DPP10 in both protein preparations. G, H, KChIP2 ASO induces bilateral mechanical hypersensitivity during D1–D5. Thermal hypersensitivity was not detected. **p < 0.05, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. ***p < 0.001, compared with the baseline (BL) on the corresponding side by Tukey's post hoc test after one-way ANOVA. I–K, In rats treated with KChIP2 ASO, Kv4.3-, KChIP1- and KChIP2-IR in L5 DRG neurons were reduced on D4. L, In rats treated with KChIP1 ASO, KChIP2-IR in L5 DRG neurons was also reduced on D4. Data are mean ± SD (n = 3). *p < 0.05, compared with vehicle (normalized to 1; Student's t test). **p < 0.01, compared with vehicle (normalized to 1; Student's t test). ***p < 0.001, compared with vehicle (normalized to 1; Student's t test).

Techniques Used: Injection, Western Blot, Isolation

Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.
Figure Legend Snippet: Intrathecal ASO injections do not affect KChIP1, KChIP2, and DPP10 expression in the spinal cord. Rats were intrathecally injected with ASO for LacZ (Z), Kv4.3, KChIP1, KChIP2, or DPP10 during D1–D3 and killed on D4. Sections of the L5 spinal cord segment were immunostained. A–C, KChIP1-, KChIP2-, or DPP10-IR in the dorsal spinal cord (on either side) is similar between each ASO group and the vehicle (V) group. Scale bar, 210 μm. D–F, Quantitative data of A–C. Data are mean ± SD (n = 3), compared with vehicle by Student's t test.

Techniques Used: Expressing, Injection

Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.
Figure Legend Snippet: Detection of a Kv4.3/KChIP1/KChIP2/DPP10 complex in the DRG. Total proteins (Total), plasma membrane proteins (PM), and rough ER proteins (rER) were isolated from rat lumbar DRGs, respectively. A, Representative Western blot data show Kv4.3, KChIP1, KChIP2, and DPP10 in each protein preparation. Cadherin and calnexin are markers for the PM and rER, respectively. The purity of PM proteins was confirmed by the presence of cadherin and the absence of calnexin, whereas the purity of rER proteins was confirmed by the presence of calnexin and the absence of cadherin. B, C, In addition to immunoprecipitation of Kv4.3, rabbit anti-Kv4.3 antibody (α-Kv4.3) coimmunoprecipitates KChIP1, KChIP2, and DPP10 from the PM proteins (B) and rER proteins (C), respectively. Nonspecific rabbit IgG was used as a control of immunoprecipitation, and “extract” indicates a bead-only loading control.

Techniques Used: Isolation, Western Blot, Immunoprecipitation

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86
    NeuroMab mouse anti kchip2 k60 73
    Transcripts showing statistically most significant LA expression differences between young and old swine.
    Mouse Anti Kchip2 K60 73, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti kchip2 k60 73/product/NeuroMab
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti kchip2 k60 73 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    86
    NeuroMab mouse monoclonal anti kchip2
    Transcripts showing statistically most significant LA expression differences between young and old swine.
    Mouse Monoclonal Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal anti kchip2/product/NeuroMab
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse monoclonal anti kchip2 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    86
    NeuroMab mouse anti kchip2
    Transcripts showing statistically most significant LA expression differences between young and old swine.
    Mouse Anti Kchip2, supplied by NeuroMab, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti kchip2/product/NeuroMab
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    mouse anti kchip2 - by Bioz Stars, 2024-07
    86/100 stars
      Buy from Supplier

    Image Search Results


    Transcripts showing statistically most significant LA expression differences between young and old swine.

    Journal: PLoS ONE

    Article Title: NHE Isoform Switching and KChIP2 Upregulation in Aging Porcine Atria

    doi: 10.1371/journal.pone.0082951

    Figure Lengend Snippet: Transcripts showing statistically most significant LA expression differences between young and old swine.

    Article Snippet: Supernatants (50 µg protein/lane) were heated to 45°C and size-fractionated on 4–12% Bis-Tris gels (Invitrogen, NY, USA), transferred electrophoretically onto nitrocellulose membranes (VWR) and probed with mouse anti-KChIP2 K60/73 (UC Davis/NIH NeuroMab Facility) and mouse anti-GAPDH (Sigma) antibodies.

    Techniques: Expressing

    A. Mean KChIP2 ( KCNIP2 ) transcript expression quantified by real-time qPCR, standardized to GAPDH expression in each sample and then normalized to expression measured from a single young pig LA sample. **p<0.01, old v young; all others p>0.05; n = 3–5. B. Upper : mean cardiac KChIP2 protein expression visualized by western blotting, standardized by total protein for loading. Lower : GAPDH expression for comparison. Each lane is from a different individual. C. Mean cardiac KChIP2 protein expression quantified by band densitometry of blots as in panel F, normalized to GAPDH expression. *p<0.05 old v young; n = 3–4. D. In silico modeling data showing the predicted effects of 3.8-fold KChIP2 upregulation on human atrial myocyte I to ( lower ) and action potential morphology ( upper ).

    Journal: PLoS ONE

    Article Title: NHE Isoform Switching and KChIP2 Upregulation in Aging Porcine Atria

    doi: 10.1371/journal.pone.0082951

    Figure Lengend Snippet: A. Mean KChIP2 ( KCNIP2 ) transcript expression quantified by real-time qPCR, standardized to GAPDH expression in each sample and then normalized to expression measured from a single young pig LA sample. **p<0.01, old v young; all others p>0.05; n = 3–5. B. Upper : mean cardiac KChIP2 protein expression visualized by western blotting, standardized by total protein for loading. Lower : GAPDH expression for comparison. Each lane is from a different individual. C. Mean cardiac KChIP2 protein expression quantified by band densitometry of blots as in panel F, normalized to GAPDH expression. *p<0.05 old v young; n = 3–4. D. In silico modeling data showing the predicted effects of 3.8-fold KChIP2 upregulation on human atrial myocyte I to ( lower ) and action potential morphology ( upper ).

    Article Snippet: Supernatants (50 µg protein/lane) were heated to 45°C and size-fractionated on 4–12% Bis-Tris gels (Invitrogen, NY, USA), transferred electrophoretically onto nitrocellulose membranes (VWR) and probed with mouse anti-KChIP2 K60/73 (UC Davis/NIH NeuroMab Facility) and mouse anti-GAPDH (Sigma) antibodies.

    Techniques: Expressing, Western Blot, In Silico